University Of Pittsburgh
Work out robotics value equation before adoption

Adoption of robotic systems by orthopedic surgeons has been slow and limited due to lack of improved efficiencies, the requirement of significant capital expenditure and no convincing evidence of changes in outcomes, according to an article in The Journal of Arthroplasty, by Brian S. Parsley, MD, in 2018. However, since these were first introduced in the specialty, robotics have continued to evolve, Parsley noted, which provide greater opportunities for advanced surgical planning, optimization of component placement and improved overall mechanical alignment.
Residual cancer burden predicts long-term outcomes across breast cancer subtypes
Menopausal hormone therapy regimens have opposite lasting effects on breast cancer incidence
Margetuximab extends survival in relapsed HER2-positive metastatic breast cancer

SAN ANTONIO — Margetuximab plus chemotherapy conferred a numerically small but statistically significant PFS and OS compared with trastuzumab plus chemotherapy for patients with relapsed or refractory HER2-positive metastatic breast cancer, according to results of a second interim analysis of the randomized phase 3 SOPHIA trial presented at San Antonio Breast Cancer Symposium.